{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:30:45Z","timestamp":1788996645144,"version":"build-2803163510"},"reference-count":109,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jcin.2019.08.055","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:31:55Z","timestamp":1578357115000},"page":"1-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Refractory Angina"],"prefix":"10.1016","volume":"13","author":[{"given":"Guglielmo","family":"Gallone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Baldetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Tzanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Gramegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeem","family":"Latib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2019.08.055_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/CIRCULATIONAHA.113.004042","article-title":"Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010","volume":"129","author":"Moran","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2019.08.055_bib2","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1016\/j.jacc.2018.09.052","article-title":"Medical therapy for long-term prevention of atherothrombosis following an acute coronary syndrome","volume":"72","author":"Gallone","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nrcardio.2017.131","article-title":"Expert consensus document: a 'diamond' approach to personalized treatment of angina","volume":"15","author":"Ferrari","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ahj.2007.12.005","article-title":"Clinical and research issues regarding chronic advanced coronary artery disease Part II: Trial design, outcomes, and regulatory issues","volume":"155","author":"Jolicoeur","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2019.08.055_bib5","first-page":"435","article-title":"Clinical and research issues regarding chronic advanced coronary artery disease. Part II: Trial design, outcomes, and regulatory issues","volume":"155","author":"Jolicoeur","year":"2008","journal-title":"Am\u00a0Heart\u00a0J"},{"key":"10.1016\/j.jcin.2019.08.055_bib6","first-page":"S50","article-title":"Patients with coronary artery disease unsuitable for revascularization: definition, general principles, and a classification","volume":"28","author":"Jolicoeur","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrcardio.2013.200","article-title":"Treatment of refractory angina in patients not suitable for revascularization","volume":"11","author":"Henry","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/euhj.2001.2706","article-title":"The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina","volume":"23","author":"Mannheimer","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2019.08.055_bib9","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Task Force","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2019.08.055_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2018.04.061","article-title":"Coronary microvascular dysfunction in patients with stable coronary artery disease: the CE-MARC 2 coronary physiology sub-study","volume":"266","author":"Corcoran","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib11","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","article-title":"Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease","volume":"8","author":"Sara","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2019.08.055_bib12","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.jacc.2018.07.106","article-title":"Coronary physiology beyond coronary flow reserve in microvascular angina: JACC State-of-the-Art Review","volume":"72","author":"Gould","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib13","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/eurheartj\/eht165","article-title":"Long-term survival in patients with refractory angina","volume":"34","author":"Henry","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2019.08.055_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/heartjnl-2017-312755","article-title":"Percutaneous coronary intervention for stable coronary artery disease","volume":"105","author":"Al-Lamee","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.jcin.2019.08.055_bib15","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/0002-9149(88)91180-0","article-title":"\"Microvascular angina\" as a cause of chest pain with angiographically normal coronary arteries","author":"Cannon","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jama.1995.03520350065031","article-title":"The sensitive heart: a syndrome of abnormal cardiac pain perception","volume":"273","author":"Cannon","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2019.08.055_bib17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jacc.2012.02.082","article-title":"Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!","volume":"60","author":"Marzilli","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2014.160","article-title":"Coronary microvascular dysfunction: mechanisms and functional assessment","volume":"12","author":"Camici","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/1153643-S0-000000000-00000","article-title":"Persistent angina: the Araba Phoenix of cardiology","volume":"10 Suppl 1","author":"Marzilli","year":"2010","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jcin.2019.08.055_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2017.07.105","article-title":"Angina after percutaneous coronary intervention: the need for precision medicine","volume":"248","author":"Niccoli","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jamainternmed.2013.12855","article-title":"Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials","volume":"174","author":"Stergiopoulos","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jcin.2019.08.055_bib22","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/CIRCULATIONAHA.113.008507","article-title":"Effects of sex on coronary microvascular dysfunction and cardiac outcomes","volume":"129","author":"Murthy","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2019.08.055_bib23","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","article-title":"Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial","volume":"72","author":"Ford","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib24","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jacc.2012.01.055","article-title":"Myocardial oxygenation in coronary artery disease: Insights from blood oxygen level-dependent magnetic resonance imaging at 3 Tesla","volume":"59","author":"Arnold","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jcmg.2018.12.033","article-title":"Reassessing the meaning of fractional flow reserve and myocardial perfusion imaging: hemodynamical significance does not equal ischemia","volume":"12","author":"Gallone","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcin.2019.08.055_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.RES.0000049104.57549.03","article-title":"Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest","volume":"92","author":"Fallavollita","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.jcin.2019.08.055_bib27","doi-asserted-by":"crossref","first-page":"O2","DOI":"10.1016\/S1520-765X(01)90147-6","article-title":"Changes in cardiac metabolism: a critical step from stable angina to ischaemic cardiomyopathy","volume":"3","author":"Stanley","year":"2001","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.jcin.2019.08.055_bib28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/j.2040-4603.2015.tb00616.x","article-title":"Mechanisms of cardiac pain","volume":"5","author":"Foreman","year":"2015","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jacc.2018.12.064","article-title":"Autonomic nervous system dysfunction: JACC Focus Seminar","volume":"73","author":"Goldberger","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-540-79090-7_6","article-title":"Regulation of cardiac afferent excitability in ischemia","author":"Fu","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jcin.2019.08.055_bib31","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.0000142618.20278.7A","article-title":"Sensing tissue ischemia: another new function for capsaicin receptors?","volume":"110","author":"Pan","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2019.08.055_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0735-1097(94)90306-9","article-title":"Substance P potentiates the algogenic effects of intraarterial infusion of adenosine","volume":"24","author":"Gaspardone","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/07853890008995938","article-title":"The brain-heart axis in the perception of cardiac Pain: the elusive link between ischaemia and pain","volume":"32","author":"Rosen","year":"2000","journal-title":"Ann Med"},{"key":"10.1016\/j.jcin.2019.08.055_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(94)92755-3","article-title":"Central nervous pathways mediating angina pectoris","volume":"344","author":"Rosen","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2019.08.055_bib35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-124-11-199606010-00001","article-title":"Silent ischemia as a central problem: Regional brain activation compared in silent and painful myocardial ischemia","volume":"124","author":"Rosen","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcin.2019.08.055_bib36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/heart.87.6.513","article-title":"Central neural contribution to the perception of chest pain in cardiac syndrome X","volume":"87","author":"Rosen","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.jcin.2019.08.055_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pain.2008.03.015","article-title":"Spinal cord stimulation normalizes abnormal cortical pain processing in patients with cardiac syndrome X","volume":"139","author":"Sestito","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.jcin.2019.08.055_bib38","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jacc.2017.12.046","article-title":"Diagnosis of microvascular angina using cardiac magnetic resonance","volume":"71","author":"Liu","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib39","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.98.25.2800","article-title":"Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia","volume":"98","author":"Losordo","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2019.08.055_bib40","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2004.12.068","article-title":"Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial","volume":"45","author":"Kastrup","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib41","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/01.CIR.100.5.468","article-title":"Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease","volume":"100","author":"Rosengart","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2019.08.055_bib42","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/01.CIR.103.17.2138","article-title":"Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia","volume":"103","author":"Vale","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2019.08.055_bib43","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/eurheartj\/ehx352","article-title":"Adenoviral intramyocardial VEGF-DDeltaNDeltaC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I\/IIa study with 1-year follow-up","volume":"38","author":"Hartikainen","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2019.08.055_bib44","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/hc1102.105595","article-title":"Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris","volume":"105","author":"Grines","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2019.08.055_bib45","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0735-1097(03)00988-4","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina","volume":"42","author":"Grines","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib46","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacc.2007.06.010","article-title":"Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials","volume":"50","author":"Henry","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib47","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2019.08.055_bib48","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/gerona\/glv180","article-title":"Endothelial progenitor cell levels predict future physical function: an exploratory analysis from the VA Enhanced Fitness Study","volume":"71","author":"Povsic","year":"2016","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jcin.2019.08.055_bib49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCRESAHA.116.304187","article-title":"Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease","volume":"116","author":"Patel","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jcin.2019.08.055_bib50","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/CIRCULATIONAHA.106.644518","article-title":"CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells","volume":"114","author":"Kawamoto","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2019.08.055_bib51","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1161\/CIRCULATIONAHA.106.687376","article-title":"Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I\/IIa double-blind, randomized controlled trial","volume":"115","author":"Losordo","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2019.08.055_bib52","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/CIRCRESAHA.111.245993","article-title":"Intramyocardial, autologous CD34+ cell therapy for refractory angina","volume":"109","author":"Losordo","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jcin.2019.08.055_bib53","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3727\/096368916X691484","article-title":"Autologous CD34(+) cell therapy for refractory angina: 2-year outcomes from the ACT34-CMI study","volume":"25","author":"Henry","year":"2016","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jcin.2019.08.055_bib54","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jcin.2016.05.003","article-title":"The RENEW trial: efficacy and safety of intramyocardial autologous CD34(+) cell administration in patients with refractory angina","volume":"9","author":"Povsic","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2019.08.055_bib55","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/eurheartj\/ehx764","article-title":"Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials","volume":"39","author":"Henry","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2019.08.055_bib56","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1097\/CCM.0000000000001138","article-title":"Intracoronary transfusion of circulation-derived CD34+ cells improves left ventricular function in patients with end-stage diffuse coronary artery disease unsuitable for coronary intervention","volume":"43","author":"Lee","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcin.2019.08.055_bib57","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1097\/CCM.0000000000003051","article-title":"The five-year clinical and angiographic follow-up outcomes of intracoronary transfusion of circulation-derived CD34+ cells for patients with end-stage diffuse coronary artery disease unsuitable for coronary intervention-phase i clinical trial","volume":"46","author":"Sung","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcin.2019.08.055_bib58","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/CIRCRESAHA.115.303463","article-title":"Selected CD133(+) progenitor cells to promote angiogenesis in patients with refractory angina: final results of the PROGENITOR randomized trial","volume":"115","author":"Jimenez-Quevedo","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jcin.2019.08.055_bib59","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/CIRCRESAHA.116.309009","article-title":"Effects of transendocardial delivery of bone marrow-derived CD133(+) cells on left ventricle perfusion and function in patients with refractory angina: final results of randomized, double-blinded, placebo-controlled REGENT-VSEL trial","volume":"120","author":"Wojakowski","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jcin.2019.08.055_bib60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13287-018-0969-z","article-title":"Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133(+) cells in ischemic refractory cardiomyopathy trial (RECARDIO)","volume":"9","author":"Bassetti","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcin.2019.08.055_bib61","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1136\/heartjnl-2016-309642","article-title":"Reconsidering the back door approach by targeting the coronary sinus in ischaemic heart disease","volume":"102","author":"De Maria","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.jcin.2019.08.055_bib62","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/jama.1955.02960300008003","article-title":"Scientific basis for the surgical treatment of coronary artery disease","volume":"159","author":"Beck","year":"1955","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2019.08.055_bib63","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/eurheartj\/ehx486","article-title":"The Reducer device in patients with angina pectoris: mechanisms, indications, and perspectives","volume":"39","author":"Konigstein","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2019.08.055_bib64","article-title":"Technical aspects in Coronary Sinus Reducer implantation","author":"Giannini","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2019.08.055_bib65","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction","volume":"356","author":"Camici","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2019.08.055_bib66","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.4244\/EIJV9I10A196","article-title":"Transcatheter treatment for refractory angina with the Coronary Sinus Reducer","volume":"9","author":"Konigstein","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2019.08.055_bib67","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.jacc.2007.01.061","article-title":"Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study","volume":"49","author":"Banai","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib68","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1016\/j.jacc.2018.09.061","article-title":"First-in-human use of coronary sinus reducer in patients with refractory angina","volume":"72","author":"Parikh","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib69","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMoa1402556","article-title":"Efficacy of a device to narrow the coronary sinus in refractory angina","volume":"372","author":"Verheye","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2019.08.055_bib70","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12471-016-0862-2","article-title":"Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: a single-centre real-world experience","volume":"24","author":"Abawi","year":"2016","journal-title":"Neth Heart J"},{"key":"10.1016\/j.jcin.2019.08.055_bib71","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijcard.2018.06.116","article-title":"Safety and efficacy of the reducer: a multi-center clinical registry - REDUCE study","volume":"269","author":"Giannini","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib72","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jcin.2017.06.062","article-title":"First experience with the coronary sinus reducer system for the management of refractory angina in patients without obstructive coronary artery disease","volume":"10","author":"Giannini","year":"2017","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2019.08.055_bib73","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijcard.2019.05.026","article-title":"Safety and efficacy of Coronary Sinus Reducer implantation at 2-year follow-up","volume":"292","author":"Ponticelli","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib74","doi-asserted-by":"crossref","DOI":"10.1093\/ehjqcco\/qcz027","article-title":"Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients","author":"Gallone","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jcin.2019.08.055_bib75","doi-asserted-by":"crossref","first-page":"A260","DOI":"10.1016\/S0735-1097(18)30801-5","article-title":"The coronary sinus reducer improves angina, ischemia and physical activity in patients with severe angina pectoris: a single center experience","volume":"71","author":"Konigstein","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib76","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jcin.2018.09.032","article-title":"Coronary Sinus Reducer implantation to reduce the ischemic burden in refractory angina","volume":"12","author":"Gallone","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2019.08.055_bib77","article-title":"The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris","author":"Tzanis","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2019.08.055_bib78","doi-asserted-by":"crossref","first-page":"e009148","DOI":"10.1161\/CIRCIMAGING.119.009148","article-title":"Patterns of regional myocardial perfusion following coronary sinus reducer implantation","volume":"12","author":"Giannini","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcin.2019.08.055_bib79","article-title":"Improved myocardial function with coronary sinus Reducer in a patient with refractory angina and heart failure with reduced ejection fraction","author":"Gallone","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib80","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.hlc.2016.04.013","article-title":"Increases in cardiac output and oxygen consumption during enhanced external counterpulsation","volume":"25","author":"Ahlbom","year":"2016","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jcin.2019.08.055_bib81","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0735-1097(99)00140-0","article-title":"The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes","volume":"33","author":"Arora","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151822","article-title":"Does enhanced external counterpulsation (EECP) significantly affect myocardial perfusion?: a systematic review and meta-analysis","volume":"11","author":"Qin","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jcin.2019.08.055_bib83","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jacc.2014.07.017","volume":"64","author":"Fihn","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib84","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.carrev.2014.10.011","article-title":"The beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina","volume":"16","author":"Alunni","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jcin.2019.08.055_bib85","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1755-5922.2012.00313.x","article-title":"Cardiac shock wave therapy for chronic refractory angina pectoris. A prospective placebo-controlled randomized trial","volume":"31","author":"Schmid","year":"2013","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jcin.2019.08.055_bib86","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s12471-016-0821-y","article-title":"Cardiac shockwave therapy in patients with chronic refractory angina pectoris","volume":"24","author":"Vainer","year":"2016","journal-title":"Neth Heart J"},{"key":"10.1016\/j.jcin.2019.08.055_bib87","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1253\/circj.CJ-09-1028","article-title":"Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris","volume":"74","author":"Kikuchi","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.jcin.2019.08.055_bib88","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12947-017-0102-y","article-title":"Cardiac shock-wave therapy in the treatment of coronary artery disease: systematic review and meta-analysis","volume":"15","author":"Burneikaite","year":"2017","journal-title":"Cardiovasc Ultrasound"},{"key":"10.1016\/j.jcin.2019.08.055_bib89","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/hrt.2009.185769","article-title":"NICE evaluation of transmyocardial laser revascularisation and percutaneous laser revascularisation for refractory angina","volume":"96","author":"Schofield","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.jcin.2019.08.055_bib90","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jacc.2005.06.079","article-title":"A\u00a0blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease","volume":"46","author":"Leon","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib91","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.jacc.2012.07.012","volume":"60","author":"Fihn","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib92","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.150.3699.971","article-title":"Pain mechanisms: a new theory","volume":"150","author":"Melzack","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.jcin.2019.08.055_bib93","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1056\/NEJM196712142772402","article-title":"Relief of angina pectoris by electrical stimulation of the carotid-sinus nerves","volume":"277","author":"Braunwald","year":"1967","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2019.08.055_bib94","first-page":"543","article-title":"Transcutaneous electrical nerve stimulation in unstable angina pectoris","volume":"8","author":"Borjesson","year":"1997","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jcin.2019.08.055_bib95","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/0002-8703(87)90537-0","article-title":"Catecholamine metabolism during pacing-induced angina pectoris and the effect of transcutaneous electrical nerve stimulation","volume":"114","author":"Emanuelsson","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2019.08.055_bib96","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/01.CIR.71.2.308","article-title":"The effects of transcutaneous electrical nerve stimulation in patients with severe angina pectoris","volume":"71","author":"Mannheimer","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2019.08.055_bib97","doi-asserted-by":"crossref","first-page":"H311","DOI":"10.1152\/ajpheart.00087.2006","article-title":"Preemptive, but not reactive, spinal cord stimulation mitigates transient ischemia-induced myocardial infarction via cardiac adrenergic neurons","volume":"292","author":"Southerland","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib98","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/ehjci\/jeu276","article-title":"Effect of spinal cord stimulation on myocardial perfusion reserve in patients with refractory angina pectoris","volume":"16","author":"Saraste","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcin.2019.08.055_bib99","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/01.CIR.97.12.1157","article-title":"Electrical stimulation versus coronary artery bypass surgery in severe angina pectoris: the ESBY study","volume":"97","author":"Mannheimer","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2019.08.055_bib100","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/hrt.2006.100784","article-title":"Thoracic spinal cord stimulation improves functional status and relieves symptoms in patients with refractory angina pectoris: the first placebo-controlled randomised study","volume":"93","author":"Eddicks","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.jcin.2019.08.055_bib101","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ijcard.2016.10.105","article-title":"Efficacy of spinal cord stimulation as an adjunct therapy for chronic refractory angina pectoris","volume":"227","author":"Imran","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2019.08.055_bib102","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/eurheartj\/ehi089","article-title":"Effect of spinal cord stimulation on spontaneous and stress-induced angina and 'ischemia-like' ST-segment depression in patients with cardiac syndrome X","volume":"26","author":"Lanza","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2019.08.055_bib103","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.rapm.2006.02.001","article-title":"Subcutaneous neuromodulating implant targeted at the site of pain","volume":"31","author":"Goroszeniuk","year":"2006","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.jcin.2019.08.055_bib104","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.CIR.102.7.742","article-title":"Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy","volume":"102","author":"Nademanee","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2019.08.055_bib105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jvs.2011.01.069","article-title":"Thoracic sympathectomy for digital ischemia: a summary of evidence","volume":"54","author":"Coveliers","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2019.08.055_bib106","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/2049463714549775","article-title":"Temporary sympathectomy in chronic refractory angina: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Denby","year":"2015","journal-title":"Br J Pain"},{"key":"10.1016\/j.jcin.2019.08.055_bib107","doi-asserted-by":"crossref","first-page":"e1332","DOI":"10.4244\/EIJ-D-18-00144","article-title":"Coronary vasospastic angina: a rare case of ergonovine positivity and curative bilateral cardiac sympathectomy","volume":"14","author":"Sharma","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2019.08.055_bib108","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1510\/icvts.2005.118976","article-title":"Endoscopic thoracic sympathectomy--its effect in the treatment of refractory angina pectoris","volume":"5","author":"Stritesky","year":"2006","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jcin.2019.08.055_bib109","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJM198407053110106","article-title":"Radiofrequency percutaneous upper-thoracic sympathectomy. Technique and review of indications","volume":"311","author":"Wilkinson","year":"1984","journal-title":"N\u00a0Engl J Med"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879819320588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879819320588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:10:47Z","timestamp":1761847847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879819320588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1936879819320588"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2019.08.055","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refractory Angina","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2019.08.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}